The medicine is a generic version of Swiss pharmaceutical company Novartis AG's Zometa injection Hyderabad: Aurobindo Pharma Ltd became the latest Indian generic maker to get US Food and Drug Administration (USFDA) approval to launch zoledronic acid ... Livemint.com, 19 minutes ago
Aurobindo in fray for $1.5b Teva portfolio - The Financial Chronicle, 2 months ago
:54 PM UK veterinary pharmaceutical company Norbrook Laboratories hasrecruited a former Novartis Animal Health marketing executive to be its newglobal head of sales and marketing. Richard Palmer has already started working at the ...Agra Net, 1 week ago Global Encephalitis Vaccination Market Professional Survey Report 2016 - Novartis Sanofi Chengdu Institute of Biological Products Wuhan Institute of Biological Products Lanzhou Institute of Biological Products MyNewsDesk, 2 days ago Smart Wearables in Healthcare, 2016-2030 - 250 Smart Wearables Developed by Over 150 Companies - Research and Markets DMN Final Cut Pro, 1 day ago Global Urological Cancer Market Forecast to 2022 - Key Players are Novartis, Pfizer & AstraZeneca - Research and Markets 4 Traders, 5 days ago
Novartis announces positive top-line results from ASCEND-4, a Phase III trial of Zykadia® in untreated adult A...
In a Phase III clinical study, Zykadia® extended progression-free survival (PFS) when compared with standard chemotherapy, including maintenance Novartis is moving forward with global regulatory submissions for this indication; full results ...TeleTrader.com, 5 days ago Ilaris receives three simultaneous FDA approvals for periodic fever syndromes Healio, 3 days ago Fovista Results Could See Novartis Dig Deep, And Gilead's NASH Data Seeking Alpha, 4 days ago Novartis' new Zykadia data put first-line nod in sight FiercePharma, 4 days ago
These 14 prescription brands acquired by the company earlier this year will be transferred from Novartis Pharma K.K. to Sun Pharmas subsidiary in Japan beginning October 2016.India Infoline, 3 weeks ago A Double Dose of Trouble at Novartis Yahoo! Finance, 5 days ago Sun Pharma inks distribution alliance with Mitsubishi Tanabe for 14 brands First Post.com, 3 weeks ago Sun Pharma founder Dilip Shanghvi heads this year's list of Asian pharma billionaires FiercePharma, 1 day ago
More from: , Business Standard...and 1 other sources
Novartis's Zykadia drug performed well against a rare form of lung cancer, the Swiss company said on Friday, citing a study it hopes will help it win expanded regulatory approval for the use of the drug. But it faces competition from a medicine produced by ...Reuters, 5 days ago UPDATE 1-Novartis's Zykadia gets positive results, faces Roche pressure Business Insider, 4 days ago Novartis Zykadia gets positive results Pharma Live, 4 days ago Novartis intensifies Entresto push with new analysis Yahoo! India, 1 week ago
But pharma company maintains there is no shortage Mumbai, Sept 9: Earlier this week, a petition addressed to Health Minister JP Nadda raised concerns over the non-availability of Desferal, an injectable drug used to reduce excess iron in the blood for people ...Business Line, 2 weeks ago
July 29, 2016 Last Updated at 10:17 ISTBusiness Standard, 2 months ago Novartis India: Outcome of board meeting Money Control, 2 months ago Novartis India's board meeting on July 28, 2016 Money Control, 2 months ago Novartis India to turn ex-date for buyback Business Line, 2 months ago
The company had posted a net profit of Rs 13.34 crore for the corresponding period of the previous fiscal, Novartis India said in a filing on BSE.Money Control, 2 months ago Novartis India Q1 net at Rs 19 crore Business Standard, 2 months ago
Nouscom, an oncology company developing patient specific cancer vaccines based on a clinically validated genetic vaccine platform, today announced the appointment of Dr Marina Udier Blagovic as Chief Operating Officer (COO). The new position has ...4 Traders, 1 day ago Nouscom Appoints New Chief Operating Officer and Strengthens the Board of Directors TickerTech.com, 2 days ago
Familiarity with Taltz is significantly higher compared to the prior quarter, but it's user base has remained stable at around 30% since Q2, around half of that of Cosentyx . In an attribute analysis completed by all respondents, Cosentyx was rated ...BioMedReports, 1 week ago Eli Lilly's Taltz And Novartis Cosentyx Introduce Disruption To The Psoriasis Market, According... Freshnews.com, 1 week ago
More from: , Minyanville...and 6 other sources
on your WebpageAdd Widget >Get your members hooked!